Illumina Backs Twist Bioscience

San Diego-based life sciences equipment maker Illumina is the lead investor in San Francisco-based Twist Bioscience, a developer of a synthetic DNA manufacturing technology. Twist Bioscience said it raised $37M in a Series C, led by Illumina, and also included Fidelity Management and Research Company. Foresite Capital Management , Nick and Joby Pritzker (via their fund, Tao Invest), plus ARCH Venture Partners, Paladin Capital Group, Yuri Milner, and others. Twist Bioscience says it has now raised $82.1M in venture funding. More information »